Professor Emeritus Marta Weinstock-Rosin, who developed what is now one of the most commonly-used treatments for Alzheimer's and Parkinson's, Rivastigmine, is being honoured for her work in the field of medicine
Shalom Life's mission is to share, discuss and inspire our readers with stories about Jewish culture and life.
Shalom Life launched in 2009 and has become Canada's largest independent Jewish news source dedicated to covering culture, arts, society, technology, business, and general news, both locally and internationally.
Shalom Life's content has also been syndicated on some of the world's top publications including Macleans, National Post, ABC News, Ynet, Forbes, USA Today and many more, helping expand it's reach to millions of other readers.
Shalom Life's head office is in Toronto, Canada. Shalom Life has recently expanded into Los Angeles, with plans of opening offices across the United States.